Lesser-Known Aspects of Deep Brain Stimulation for Parkinson's Disease: Programming Sessions, Hardware Surgeries, Residential Care Admissions, and Deaths.

Neuromodulation : Journal of the International Neuromodulation Society
San San XuWesley Thevathasan

Abstract

The long-term treatment burden, duration of community living, and survival of patients with Parkinson's disease (PD) after deep brain stimulation (DBS) implantation are unclear. This study aims to determine the frequency of programming, repeat hardware surgeries (of the intracranial electrode, implantable pulse generator [IPG], and extension-cable), and the timings of residential care and death in patients with PD treated with DBS. In this cross-sectional, population-based study, individual-level data were collected from the Australian government covering a 15-year period (2002-2016) on 1849 patients with PD followed from DBS implantation. The mean DBS implantation age was 62.6 years and mean follow-up 5.0 years. Mean annual programming rates were 6.9 in the first year and 2.8 in subsequent years. 51.4% of patients required repeat hardware surgery. 11.3% of patients had repeat intracranial electrode surgery (including an overall 1.1% of patients who were completely explanted). 47.6% of patients had repeat IPG/extension-cable surgery including for presumed battery depletion. 6.2% of patients had early repeat IPG/extension-cable surgery (within one year of any previous such surgery). Thirty-day postoperative mortality was 0.3% af...Continue Reading

References

Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A SchragN Quinn
Aug 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M A HelyP M Williamson
Apr 12, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Carole JointTipu Aziz
May 23, 2002·Neurosurgery·Michael Y OhAndres M Lozano
Nov 16, 2002·Archives of Neurology·Connie MarrasAnthony E Lang
Apr 15, 2003·Journal of Neurosurgery·Atsushi UmemuraGordon H Baltuch
Jul 26, 2005·Acta neurochirurgica·P Blomstedt, M I Hariz
Jul 1, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Andre MachadoAlim-Louis Benabid
Dec 7, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Michael W M SchüpbachYves Agid
Mar 24, 2007·Parkinsonism & Related Disorders·William G OndoKevin D Vuong
Nov 8, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Aleksandar Videnovic, Leo Verhagen Metman
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyJohn G L Morris
Sep 18, 2009·Brain : a Journal of Neurology·M SelikhovaA J Lees
Apr 8, 2010·Brain : a Journal of Neurology·Peter A KempsterAndrew J Lees
Jun 4, 2010·The New England Journal of Medicine·Kenneth A FollettUNKNOWN CSP 468 Study Group
Aug 31, 2010·Brain : a Journal of Neurology·Alfonso FasanoAlberto Albanese
Oct 13, 2010·Archives of Neurology·Jeff M BronsteinMahlon R DeLong
Dec 3, 2010·Stereotactic and Functional Neurosurgery·Casey H HalpernJurg L Jaggi
Feb 5, 2011·Stereotactic and Functional Neurosurgery·Paresh K Doshi
Aug 10, 2011·Archives of Neurology·Anna CastriotoElena Moro
Oct 21, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Maurizio ZibettiLeonardo Lopiano
Mar 13, 2012·Journal of Neurosurgery·Albert J Fenoy, Richard K Simpson
Apr 18, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Erwin B Montgomery
Oct 2, 2012·Experimental Neurology·Alberto PrioriSara Marceglia
Oct 19, 2012·The New England Journal of Medicine·Michael S Okun
Jul 12, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Desire NgogaHardev Pall
Jul 16, 2013·Annals of Neurology·Simon LittlePeter Brown
Feb 6, 2014·Acta Neurologica Scandinavica·B LilleengJ P Larsen
Aug 7, 2014·Stereotactic and Functional Neurosurgery·Christopher TollesonFenna Phibbs
Dec 11, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M Bang HenriksenK Østergaard
Feb 5, 2015·Internal Medicine Journal·P C PoortvlietH J Chenery
Aug 8, 2015·Neuromodulation : Journal of the International Neuromodulation Society·Steven M FalowskiRoy A E Bakay
Jan 29, 2016·Neurology·Vincent J J OdekerkenUNKNOWN NSTAPS study group
Mar 10, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Tiago A MestreMichael S Okun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.